Results 151 to 160 of about 8,503,937 (347)

Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk. [PDF]

, 1989
Kenneth G. Mann
openalex   +1 more source

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

Circulation, 2008
R. D'Agostino, R. Vasan, M. Pencina, P. Wolf, M. Cobain, J. Massaro, W. Kannel   +6 more
semanticscholar   +1 more source

Advanced Oral Delivery Systems for Nutraceuticals

Advanced Healthcare Materials, EarlyView.
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang, Linzixuan Zhang, Zhiling Zheng, Robert Langer, Ana Jaklenec   +4 more
wiley   +1 more source

Vorticity‐Facilitated Platelet Aggregation: a High Expansion‐Ratio Stenotic Microfluidic Platform Unravels the Role of Complex Flow Dynamics in Arterial Thrombosis

Advanced Healthcare Materials, EarlyView.
This study reveals how vorticity—a swirling flow pattern—enhances platelet aggregation and thrombus formation in high‐shear conditions. Using a custom microfluidic model, it is shows that vorticity promotes vWF–GPIbα interactions and calcium signaling, providing new insights into thrombosis mechanobiology and informing safer blood‐contacting medical ...
Jianfang Ren, Nurul Aisha Zainal Abidin, Allan Sun, Rui Gao, Yuxin Chen, Arian Nasser, Zihao Wang, Yunduo Charles Zhao, Alexander Dupuy, Anna Waterhouse, Qian Peter Su, Daniele Vigolo, Mike Chia Lun Wu, Lining Arnold Ju   +13 more
wiley   +1 more source

Total risk approach for noncommunicable diseases: A review of cardiovascular disease risk prediction tools for Indian setting

Indian Journal of Community and Family Medicine
Risk stratification approach considering total cardiovascular disease (CVD) risk and providing appropriate interventions is one of the WHO best-buys for tackling noncommunicable diseases (NCDs). Various risk prediction tools are available to assess total
P. Ananda Selva Das, Baridalyne Nongkynrih, Ravneet Kaur, Harshal Ramesh Salve   +3 more
doaj   +1 more source

Cardiovascular Risk Factor Reduction in the Workplace: Why and How? [PDF]

, 1985
Eleanor Schron
openalex   +1 more source

Membrane Fusion‐Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics

Advanced Healthcare Materials, EarlyView.
Membrane fusion‐inspired nanomaterials offer transformative potential in diagnostics by mimicking natural fusion processes to achieve highly sensitive and specific detection of disease biomarkers. This review highlights recent advancements in nanomaterial functionalization strategies, signal amplification systems, and stimuli‐responsive fusion designs,
Sojeong Lee, Khulan Nyamzaya, Jueun Han, Yejin Song, Jihee Lee, Jung Hyun Jo, Seungmin Bang, Eun‐Kyung Lim, Seungjoo Haam, Eunjung Kim   +9 more
wiley   +1 more source

Heart to heart: A manual of nutrition counseling for the reduction of cardiovascular disease risk factors [PDF]

, 1984
Frances A. Larkin
openalex   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis

International Journal of Women's Health, 2015
Jingbo Yu,1 Jackson Tang,2 Zhiyi Li,2 Shiva Sajjan,1 Christopher O’Regan,3 Ankita Modi,1 Vasilisa Sazonov11Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA; 2Asclepius Analytics Ltd., Wanchai,
Yu J, Tang J, Li Z, Sajjan S, O'Regan C, Modi A, Sazonov V   +6 more
doaj